Advanced Proteome Therapeutics Corporation (APC or the company) announced that its Board of Directors has appointed Dr. David Webb to the Company's Corporate Advisory Board. Dr. Webb is currently Adjunct Professor at The Scripps Research Institute (TSRI). At Scripps he has focused on several areas relevant to drug discovery including the detection of circulating tumor cells.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 151K | |
+161.77% | 6.26B | |
+2.33% | 984M | |
+41.91% | 872M | |
+30.25% | 851M | |
+1.72% | 664M | |
+5.03% | 648M | |
-.--% | 600M | |
+12.78% | 548M | |
-.--% | 500M |
- Stock Market
- Equities
- APC.H Stock
- News Advanced Proteome Therapeutics Corporation
- Advanced Proteome Therapeutics Corporation Appoints Dr. David Webb to its Corporate Advisory Board